BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20622482)

  • 1. [RIAM: bridge between Rap1 and integrin].
    Watanabe N
    Rinsho Ketsueki; 2010 Jun; 51(6):377-83. PubMed ID: 20622482
    [No Abstract]   [Full Text] [Related]  

  • 2. Rap1 controls activation of the α(M)β(2) integrin in a talin-dependent manner.
    Lim J; Dupuy AG; Critchley DR; Caron E
    J Cell Biochem; 2010 Nov; 111(4):999-1009. PubMed ID: 20665668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rap1 regulation of RIAM and cell adhesion.
    Lafuente E; Boussiotis VA
    Methods Enzymol; 2006; 407():345-58. PubMed ID: 16757337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin activation.
    Banno A; Ginsberg MH
    Biochem Soc Trans; 2008 Apr; 36(Pt 2):229-34. PubMed ID: 18363565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIAM links the ADAP/SKAP-55 signaling module to Rap1, facilitating T-cell-receptor-mediated integrin activation.
    Ménasché G; Kliche S; Chen EJ; Stradal TE; Schraven B; Koretzky G
    Mol Cell Biol; 2007 Jun; 27(11):4070-81. PubMed ID: 17403904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3.
    Watanabe N; Bodin L; Pandey M; Krause M; Coughlin S; Boussiotis VA; Ginsberg MH; Shattil SJ
    J Cell Biol; 2008 Jun; 181(7):1211-22. PubMed ID: 18573917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIAM (Rap1-interacting adaptor molecule) regulates complement-dependent phagocytosis.
    Medraño-Fernandez I; Reyes R; Olazabal I; Rodriguez E; Sanchez-Madrid F; Boussiotis VA; Reche PA; Cabañas C; Lafuente EM
    Cell Mol Life Sci; 2013 Jul; 70(13):2395-410. PubMed ID: 23420480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding properties and stability of the Ras-association domain of Rap1-GTP interacting adapter molecule (RIAM).
    Takala H; Ylänne J
    PLoS One; 2012; 7(4):e31955. PubMed ID: 22523535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3.
    Han J; Lim CJ; Watanabe N; Soriani A; Ratnikov B; Calderwood DA; Puzon-McLaughlin W; Lafuente EM; Boussiotis VA; Shattil SJ; Ginsberg MH
    Curr Biol; 2006 Sep; 16(18):1796-806. PubMed ID: 16979556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation.
    Lagarrigue F; Gingras AR; Paul DS; Valadez AJ; Cuevas MN; Sun H; Lopez-Ramirez MA; Goult BT; Shattil SJ; Bergmeier W; Ginsberg MH
    Blood Adv; 2018 Sep; 2(18):2358-2368. PubMed ID: 30242097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational activation of talin by RIAM triggers integrin-mediated cell adhesion.
    Yang J; Zhu L; Zhang H; Hirbawi J; Fukuda K; Dwivedi P; Liu J; Byzova T; Plow EF; Wu J; Qin J
    Nat Commun; 2014 Dec; 5():5880. PubMed ID: 25520155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences.
    Lee HS; Lim CJ; Puzon-McLaughlin W; Shattil SJ; Ginsberg MH
    J Biol Chem; 2009 Feb; 284(8):5119-27. PubMed ID: 19098287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the Rap1 effector RIAM results in leukocyte adhesion deficiency due to impaired β2 integrin function in mice.
    Klapproth S; Sperandio M; Pinheiro EM; Prünster M; Soehnlein O; Gertler FB; Fässler R; Moser M
    Blood; 2015 Dec; 126(25):2704-12. PubMed ID: 26337492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optogenetics-based localization of talin to the plasma membrane promotes activation of β3 integrins.
    Liao Z; Gingras AR; Lagarrigue F; Ginsberg MH; Shattil SJ
    J Biol Chem; 2021; 296():100675. PubMed ID: 33865854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inside-out integrin activation links micro- to macro-dynamics].
    Nishiya N
    Tanpakushitsu Kakusan Koso; 2006 May; 51(6 Suppl):606-15. PubMed ID: 16719319
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Rap1 and Riam to Talin1 Fine-Tune β2 Integrin Activity During Leukocyte Trafficking.
    Bromberger T; Klapproth S; Rohwedder I; Weber J; Pick R; Mittmann L; Min-Weißenhorn SJ; Reichel CA; Scheiermann C; Sperandio M; Moser M
    Front Immunol; 2021; 12():702345. PubMed ID: 34489950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talin binding to integrin beta tails: a final common step in integrin activation.
    Tadokoro S; Shattil SJ; Eto K; Tai V; Liddington RC; de Pereda JM; Ginsberg MH; Calderwood DA
    Science; 2003 Oct; 302(5642):103-6. PubMed ID: 14526080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired platelet aggregation and abnormal activation of GPIIb-IIIa.
    Gabbeta J; Rao AK
    Thromb Haemost; 1997 Oct; 78(4):1302. PubMed ID: 9365007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.